nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—Emotional disorder—Varenicline—nicotine dependence	0.0573	0.0961	CcSEcCtD
Mefloquine—HBA1—cardiovascular system—nicotine dependence	0.0372	0.169	CbGeAlD
Mefloquine—HBA2—cardiovascular system—nicotine dependence	0.0342	0.155	CbGeAlD
Mefloquine—Suicide—Varenicline—nicotine dependence	0.0241	0.0404	CcSEcCtD
Mefloquine—Balance disorder—Varenicline—nicotine dependence	0.0229	0.0384	CcSEcCtD
Mefloquine—Completed suicide—Varenicline—nicotine dependence	0.0213	0.0357	CcSEcCtD
Mefloquine—Paranoia—Varenicline—nicotine dependence	0.0183	0.0308	CcSEcCtD
Mefloquine—HBA1—brain—nicotine dependence	0.0183	0.083	CbGeAlD
Mefloquine—Suicidal ideation—Varenicline—nicotine dependence	0.0178	0.0299	CcSEcCtD
Mefloquine—ADORA2A—cardiovascular system—nicotine dependence	0.0178	0.0809	CbGeAlD
Mefloquine—HBA2—brain—nicotine dependence	0.0168	0.0762	CbGeAlD
Mefloquine—ADORA1—cardiovascular system—nicotine dependence	0.0154	0.0698	CbGeAlD
Mefloquine—Aggression—Varenicline—nicotine dependence	0.0142	0.0239	CcSEcCtD
Mefloquine—Leukocytosis—Varenicline—nicotine dependence	0.0133	0.0223	CcSEcCtD
Mefloquine—Coordination abnormal—Varenicline—nicotine dependence	0.0127	0.0214	CcSEcCtD
Mefloquine—Abnormal dreams—Varenicline—nicotine dependence	0.0124	0.0207	CcSEcCtD
Mefloquine—Influenza like illness—Varenicline—nicotine dependence	0.0121	0.0204	CcSEcCtD
Mefloquine—ADORA1—midbrain—nicotine dependence	0.012	0.0545	CbGeAlD
Mefloquine—ACHE—midbrain—nicotine dependence	0.0119	0.0542	CbGeAlD
Mefloquine—Sleep disorder—Varenicline—nicotine dependence	0.0105	0.0176	CcSEcCtD
Mefloquine—Deafness—Varenicline—nicotine dependence	0.0101	0.017	CcSEcCtD
Mefloquine—Visual disturbance—Varenicline—nicotine dependence	0.00958	0.0161	CcSEcCtD
Mefloquine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00913	0.0496	CbGpPWpGaD
Mefloquine—Affect lability—Varenicline—nicotine dependence	0.00893	0.015	CcSEcCtD
Mefloquine—Psychotic disorder—Varenicline—nicotine dependence	0.00886	0.0149	CcSEcCtD
Mefloquine—ADORA2A—brain—nicotine dependence	0.00873	0.0397	CbGeAlD
Mefloquine—Irritability—Varenicline—nicotine dependence	0.00866	0.0145	CcSEcCtD
Mefloquine—Mood swings—Varenicline—nicotine dependence	0.0086	0.0144	CcSEcCtD
Mefloquine—Cramp muscle—Varenicline—nicotine dependence	0.00817	0.0137	CcSEcCtD
Mefloquine—ADORA1—brain—nicotine dependence	0.00753	0.0343	CbGeAlD
Mefloquine—BCHE—cardiovascular system—nicotine dependence	0.0075	0.0341	CbGeAlD
Mefloquine—ACHE—brain—nicotine dependence	0.00749	0.034	CbGeAlD
Mefloquine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00712	0.0387	CbGpPWpGaD
Mefloquine—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00693	0.0116	CcSEcCtD
Mefloquine—Hepatobiliary disease—Varenicline—nicotine dependence	0.00661	0.0111	CcSEcCtD
Mefloquine—Bradycardia—Varenicline—nicotine dependence	0.00639	0.0107	CcSEcCtD
Mefloquine—Hallucination—Varenicline—nicotine dependence	0.00625	0.0105	CcSEcCtD
Mefloquine—Connective tissue disorder—Varenicline—nicotine dependence	0.00617	0.0104	CcSEcCtD
Mefloquine—Visual impairment—Varenicline—nicotine dependence	0.00605	0.0102	CcSEcCtD
Mefloquine—Erythema multiforme—Varenicline—nicotine dependence	0.00594	0.00996	CcSEcCtD
Mefloquine—Eye disorder—Varenicline—nicotine dependence	0.00587	0.00984	CcSEcCtD
Mefloquine—BCHE—midbrain—nicotine dependence	0.00586	0.0266	CbGeAlD
Mefloquine—Tinnitus—Varenicline—nicotine dependence	0.00585	0.00982	CcSEcCtD
Mefloquine—Cardiac disorder—Varenicline—nicotine dependence	0.00583	0.00978	CcSEcCtD
Mefloquine—Angiopathy—Varenicline—nicotine dependence	0.0057	0.00956	CcSEcCtD
Mefloquine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00566	0.0307	CbGpPWpGaD
Mefloquine—Mediastinal disorder—Varenicline—nicotine dependence	0.00566	0.00949	CcSEcCtD
Mefloquine—Chills—Varenicline—nicotine dependence	0.00563	0.00945	CcSEcCtD
Mefloquine—Mental disorder—Varenicline—nicotine dependence	0.0055	0.00923	CcSEcCtD
Mefloquine—Erythema—Varenicline—nicotine dependence	0.00547	0.00917	CcSEcCtD
Mefloquine—Malnutrition—Varenicline—nicotine dependence	0.00547	0.00917	CcSEcCtD
Mefloquine—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00527	0.0286	CbGpPWpGaD
Mefloquine—Muscle spasms—Varenicline—nicotine dependence	0.00525	0.00882	CcSEcCtD
Mefloquine—CYP19A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0052	0.0282	CbGpPWpGaD
Mefloquine—Vision blurred—Varenicline—nicotine dependence	0.00515	0.00864	CcSEcCtD
Mefloquine—Tremor—Varenicline—nicotine dependence	0.00512	0.00859	CcSEcCtD
Mefloquine—CYP19A1—brain—nicotine dependence	0.00511	0.0232	CbGeAlD
Mefloquine—Ill-defined disorder—Varenicline—nicotine dependence	0.00507	0.00851	CcSEcCtD
Mefloquine—Agitation—Varenicline—nicotine dependence	0.00502	0.00843	CcSEcCtD
Mefloquine—Malaise—Varenicline—nicotine dependence	0.00493	0.00827	CcSEcCtD
Mefloquine—Vertigo—Varenicline—nicotine dependence	0.00491	0.00824	CcSEcCtD
Mefloquine—Syncope—Varenicline—nicotine dependence	0.0049	0.00822	CcSEcCtD
Mefloquine—ADORA1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00484	0.0263	CbGpPWpGaD
Mefloquine—Palpitations—Varenicline—nicotine dependence	0.00483	0.0081	CcSEcCtD
Mefloquine—Loss of consciousness—Varenicline—nicotine dependence	0.0048	0.00806	CcSEcCtD
Mefloquine—Convulsion—Varenicline—nicotine dependence	0.00474	0.00794	CcSEcCtD
Mefloquine—Hypertension—Varenicline—nicotine dependence	0.00472	0.00792	CcSEcCtD
Mefloquine—Myalgia—Varenicline—nicotine dependence	0.00465	0.00781	CcSEcCtD
Mefloquine—Arthralgia—Varenicline—nicotine dependence	0.00465	0.00781	CcSEcCtD
Mefloquine—Chest pain—Varenicline—nicotine dependence	0.00465	0.00781	CcSEcCtD
Mefloquine—Anxiety—Varenicline—nicotine dependence	0.00464	0.00778	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00462	0.00775	CcSEcCtD
Mefloquine—Discomfort—Varenicline—nicotine dependence	0.0046	0.00771	CcSEcCtD
Mefloquine—Oedema—Varenicline—nicotine dependence	0.00446	0.00748	CcSEcCtD
Mefloquine—Shock—Varenicline—nicotine dependence	0.00439	0.00736	CcSEcCtD
Mefloquine—Nervous system disorder—Varenicline—nicotine dependence	0.00437	0.00734	CcSEcCtD
Mefloquine—Thrombocytopenia—Varenicline—nicotine dependence	0.00437	0.00733	CcSEcCtD
Mefloquine—Tachycardia—Varenicline—nicotine dependence	0.00435	0.0073	CcSEcCtD
Mefloquine—Skin disorder—Varenicline—nicotine dependence	0.00433	0.00727	CcSEcCtD
Mefloquine—Hyperhidrosis—Varenicline—nicotine dependence	0.00431	0.00723	CcSEcCtD
Mefloquine—CYP19A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00427	0.0232	CbGpPWpGaD
Mefloquine—Hypotension—Varenicline—nicotine dependence	0.00417	0.00699	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00406	0.00682	CcSEcCtD
Mefloquine—Insomnia—Varenicline—nicotine dependence	0.00403	0.00677	CcSEcCtD
Mefloquine—Dyspnoea—Varenicline—nicotine dependence	0.00398	0.00667	CcSEcCtD
Mefloquine—Somnolence—Varenicline—nicotine dependence	0.00397	0.00665	CcSEcCtD
Mefloquine—Dyspepsia—Varenicline—nicotine dependence	0.00393	0.00659	CcSEcCtD
Mefloquine—Decreased appetite—Varenicline—nicotine dependence	0.00388	0.00651	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00385	0.00646	CcSEcCtD
Mefloquine—Fatigue—Varenicline—nicotine dependence	0.00385	0.00645	CcSEcCtD
Mefloquine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0037	0.0201	CbGpPWpGaD
Mefloquine—BCHE—brain—nicotine dependence	0.00368	0.0167	CbGeAlD
Mefloquine—Feeling abnormal—Varenicline—nicotine dependence	0.00368	0.00617	CcSEcCtD
Mefloquine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00365	0.00612	CcSEcCtD
Mefloquine—ABCB1—cardiovascular system—nicotine dependence	0.00357	0.0163	CbGeAlD
Mefloquine—Urticaria—Varenicline—nicotine dependence	0.00354	0.00594	CcSEcCtD
Mefloquine—Abdominal pain—Varenicline—nicotine dependence	0.00353	0.00592	CcSEcCtD
Mefloquine—Body temperature increased—Varenicline—nicotine dependence	0.00353	0.00592	CcSEcCtD
Mefloquine—Hypersensitivity—Varenicline—nicotine dependence	0.00329	0.00551	CcSEcCtD
Mefloquine—Asthenia—Varenicline—nicotine dependence	0.0032	0.00537	CcSEcCtD
Mefloquine—ACHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00319	0.0173	CbGpPWpGaD
Mefloquine—Pruritus—Varenicline—nicotine dependence	0.00316	0.00529	CcSEcCtD
Mefloquine—Diarrhoea—Varenicline—nicotine dependence	0.00305	0.00512	CcSEcCtD
Mefloquine—ACHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00302	0.0164	CbGpPWpGaD
Mefloquine—Dizziness—Varenicline—nicotine dependence	0.00295	0.00495	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00293	0.0159	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00285	0.0155	CbGpPWpGaD
Mefloquine—Vomiting—Varenicline—nicotine dependence	0.00284	0.00476	CcSEcCtD
Mefloquine—Rash—Varenicline—nicotine dependence	0.00281	0.00472	CcSEcCtD
Mefloquine—Dermatitis—Varenicline—nicotine dependence	0.00281	0.00471	CcSEcCtD
Mefloquine—Headache—Varenicline—nicotine dependence	0.00279	0.00469	CcSEcCtD
Mefloquine—ABCB1—midbrain—nicotine dependence	0.00279	0.0127	CbGeAlD
Mefloquine—HBA2—Metabolism—CYP2A7—nicotine dependence	0.00277	0.0151	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0027	0.0147	CbGpPWpGaD
Mefloquine—Nausea—Varenicline—nicotine dependence	0.00265	0.00445	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—FGD1—nicotine dependence	0.0025	0.0136	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CHRNB3—nicotine dependence	0.00244	0.0133	CbGpPWpGaD
Mefloquine—CYP2D6—brain—nicotine dependence	0.00244	0.0111	CbGeAlD
Mefloquine—CYP19A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00241	0.0131	CbGpPWpGaD
Mefloquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00235	0.0128	CbGpPWpGaD
Mefloquine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00232	0.0126	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CHRNA6—nicotine dependence	0.00232	0.0126	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—CYP2A7—nicotine dependence	0.00227	0.0123	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00226	0.0123	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00226	0.0123	CbGpPWpGaD
Mefloquine—CYP19A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00224	0.0121	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00219	0.0119	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CHRNB3—nicotine dependence	0.00218	0.0118	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—CYP2A7—nicotine dependence	0.0021	0.0114	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0021	0.0114	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CHRNA6—nicotine dependence	0.00207	0.0112	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00204	0.0111	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00195	0.0106	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00195	0.0106	CbGpPWpGaD
Mefloquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00191	0.0104	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00189	0.0103	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00187	0.0102	CbGpPWpGaD
Mefloquine—ABCB1—brain—nicotine dependence	0.00175	0.00798	CbGeAlD
Mefloquine—ADORA2A—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00174	0.00948	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00174	0.00945	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—GABRA4—nicotine dependence	0.00168	0.0091	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—DRD2—nicotine dependence	0.00167	0.00908	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00166	0.00899	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00162	0.00881	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CHRNB4—nicotine dependence	0.00161	0.00873	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00159	0.00863	CbGpPWpGaD
Mefloquine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00154	0.00835	CbGpPWpGaD
Mefloquine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00152	0.00824	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—TAS2R16—nicotine dependence	0.0015	0.00816	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—GABRA4—nicotine dependence	0.00149	0.00812	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CHRNA5—nicotine dependence	0.00149	0.00811	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—DRD2—nicotine dependence	0.00147	0.00801	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00146	0.00794	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CHRNB4—nicotine dependence	0.00143	0.00779	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00142	0.0077	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.0014	0.0076	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00137	0.00743	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CHRNA5—nicotine dependence	0.00133	0.00724	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—FGD1—nicotine dependence	0.0013	0.00706	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—DRD2—nicotine dependence	0.00129	0.00701	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00128	0.00694	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00127	0.0069	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00125	0.0068	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00125	0.00678	CbGpPWpGaD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00125	0.00677	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—OPRM1—nicotine dependence	0.00123	0.00671	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CHRNA3—nicotine dependence	0.00122	0.00661	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—FGD1—nicotine dependence	0.00118	0.00641	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00117	0.00637	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00116	0.0063	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00113	0.00616	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CHRNA3—nicotine dependence	0.00109	0.0059	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00107	0.00583	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CHRNB2—nicotine dependence	0.00107	0.00582	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00106	0.00574	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00101	0.0055	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.001	0.00545	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000998	0.00542	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CHRNA4—nicotine dependence	0.000973	0.00529	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CHRNB2—nicotine dependence	0.000956	0.00519	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000953	0.00518	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000911	0.00495	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000905	0.00492	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—DRD2—nicotine dependence	0.000893	0.00485	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TAS2R16—nicotine dependence	0.000888	0.00482	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CHRNA4—nicotine dependence	0.000868	0.00472	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000702	0.00381	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000698	0.00379	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGD1—nicotine dependence	0.000697	0.00378	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000689	0.00374	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000685	0.00372	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000662	0.00359	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000653	0.00355	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—OPRM1—nicotine dependence	0.000634	0.00344	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKR1B10—nicotine dependence	0.000615	0.00334	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000539	0.00293	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGD1—nicotine dependence	0.000538	0.00292	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—DRD2—nicotine dependence	0.000504	0.00274	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000489	0.00266	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000475	0.00258	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—DRD2—nicotine dependence	0.000458	0.00249	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—WASF2—nicotine dependence	0.000434	0.00236	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP2A7—nicotine dependence	0.000422	0.00229	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—WASF1—nicotine dependence	0.000416	0.00226	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000392	0.00213	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000389	0.00212	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP2A7—nicotine dependence	0.000388	0.00211	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP2A7—nicotine dependence	0.000376	0.00204	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—OPRM1—nicotine dependence	0.000374	0.00203	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000354	0.00192	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—WASF2—nicotine dependence	0.000335	0.00182	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—WASF1—nicotine dependence	0.000321	0.00174	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000289	0.00157	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DRD2—nicotine dependence	0.000271	0.00147	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DRD2—nicotine dependence	0.000209	0.00114	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000184	0.000998	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000173	0.00094	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000113	0.000615	CbGpPWpGaD
